Biomaterial Database

Observations on Pseudomonas aeruginosa proteolytic and toxic activity in experimentally infected rats. 1992

A R Ogaard, and P Lausund, and B P Berdal

Norwegian Defence Microbiological Laboratory, Oslo.

To bypass natural resistance against Pseudomonas aeruginosa infection, a granuloma pouch model to be experimentally infected was established in rats. This experimental model also permitted easy collection of wound exudate. In general, the animals either died or became very ill and were consequently sacrificed within the first 12 days, or they (6 of 16) survived in good condition after 20 days. The virulence of recently isolated strains compared to twelve-months old subcultures of the same strains showed no major differences in clinical pattern. In the first seven days following the start of the infection, all animals presented a fall of elastase activity in the wound exudate. Toxin A was present in the exudate, sometimes in relatively high levels, but there was no correlation between toxin level and the clinical development. As a rule, spontaneous rupture of the granuloma pouch, apparently unrelated to the concentrations of either elastase or toxin A in the exudate, was beneficial to survival. In the present experimental infectious context, neither P. aeruginosa elastase nor toxin A seemed to play any isolated lethal nor pathogenetic role.

UI	MeSH Term	Description	Entries
D008297	Male		Males
D010447	Peptide Hydrolases	Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES.	Peptidase,Peptidases,Peptide Hydrolase,Protease,Proteases,Proteinase,Proteinases,Proteolytic Enzyme,Proteolytic Enzymes,Esteroproteases,Enzyme, Proteolytic,Hydrolase, Peptide
D011550	Pseudomonas aeruginosa	A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.	Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552	Pseudomonas Infections	Infections with bacteria of the genus PSEUDOMONAS.	Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D004195	Disease Models, Animal	Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.	Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005098	Exotoxins	Toxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment.	Exotoxin
D000818	Animals	Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.	Animal,Metazoa,Animalia
D014774	Virulence	The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS.	Pathogenicity
D014946	Wound Infection	Invasion of a wound by pathogenic microorganisms.	Infection, Wound,Infections, Wound,Wound Infections
D017208	Rats, Wistar	A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.	Wistar Rat,Rat, Wistar,Wistar Rats